Stada has struck a deal to partner with Italy’s NTC to market a portfolio of ophthalmic brands in the MENA region.

The latest European consumer health business news: BioGaia to distribute full probiotics portfolio in the UK; UAE's ADQ snaps up Switzerland's Acino; and Boots launches a personalized ad offering in the UK.

Sale is among options it’s considering for materials business, which is currently “managed largely on a standalone basis.” Its health, nutrition and bioscience segments account for 80% to 85% of total sales and will operate as individual business groups.

The latest appointments in Europe's consumer health industry: GSK promotes Davide Fanelli to lead its business in Spain; Stada appoints Marc van Boven to a newly-created role; and Sanofi hires Theresa von Fugle to manage its OTC operation in Germany.

Stada has struck a deal to partner with Italy’s NTC to market a portfolio of ophthalmic brands in the MENA region.

The latest European consumer health business news: BioGaia to distribute full probiotics portfolio in the UK; UAE's ADQ snaps up Switzerland's Acino; and Boots launches a personalized ad offering in the UK.

Germany's PharmaSGP blamed ongoing lockdowns for falling first-half sales, but said it could see light at the end of the tunnel, with the OTC market expected to recover in the second half of the year.

Stada reported Branded Products sales up 9% in the first half as it secured two additions to its portfolio, with a US dietary supplement brand and Nordic herbal analgesic.

The latest European business news: Sweden's Midsona expands its consumer health offering by acquiring Finland's Vitality; Karo Pharma hires J&J exec as CCO; and Navamedic sees sales rise driven by OTC growth. 

HRA’s approval for pharmacy sales of a daily oral contraceptive the UK and its ongoing work on an NDA to propose making another progestin-only contraceptive ingredient available OTC in the US stand out as additions to Perrigo’s business with the most substantial revenue impacts.

Ireland’s Office of Revenue concluded it “would not object if the Tax Appeals Commission adjusted the amount of the assessment to less than €1 billion,” says Perrigo CEO Murray Kessler.

Putative class actions against sunscreen product manufacturers for alleged violations of federal and state laws due to benzene contamination can be traced to testing reported in May by independent quality assurance firm Valisure, which bills itself as “the pharmacy that checks.”